Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

Ítems similars

• Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy
  per: Chen, Z, et al.
  Publicat: (2016)
• Myeloid sarcoma as the presenting symptom of chronic myelogenous leukemia blast crisis
  per: Levy, Rebecca A., et al.
  Publicat: (2014)
• Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy
  per: Wang, Wei, et al.
  Publicat: (2016)
• Estimations of the Increasing Prevalence and Plateau Prevalence of Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors Therapy
  per: Huang, Xuelin, et al.
  Publicat: (2012)
• Resistance to Tyrosine Kinase Inhibition Therapy for Chronic Myelogenous Leukemia: A Clinical Perspective and Emerging Treatment Options
  per: Jabbour, Elias J., et al.
  Publicat: (2013)